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Recent advances in genome engineering have opened great opportunities for engineering Chinese 
hamster ovary cells. An ideal cell line is no longer just one with high productivity, but also with high 
stability in both the productivity and product quality, and in both extensive passaging and long term 
continuous culture. Furthermore, an ideal cell line should be provided with process controllability, allowing 
the use of environmental control variables to steer its metabolism to a reaction pathway that favors the 
synthesis of product with the desired quality attributes. Importantly, these superior traits must be genetically 
and epigenetically stable and be passed on to new production lines in cell line development. We have taken 
a systems approach that integrates genomic information and metabolic model predictions to devise a 
strategy and to develop tools for attaining those goals. In tool development we reassembled the Chinese 
hamster genome and combined different versions of the genome to identify consensus segments as high 
confidence regions and annotated the genome. An expression microarray and a comparative genomic 
hybridization array for gene coding regions were designed to facilitate cell engineering studies. Using 
solution phase capture and nested PCR we also established methods of rapidly identifying the integration 
sites of transgenes on the genome. An induced pluripotent stem cell (iPSC) line was derived from Chinese 
hamster embryonic fibroblasts for use as control in genomic and epigenomic tool development. 
Furthermore, we extended our kinetic model for cell metabolism to link with the glycosylation model and 
now embark on devising a reduced model suitable for systems optimization. 
The study involves surveying an established producing line and creating cell lines with a single 
copy transgene of GFP reporter or of IgG-GFP. The design of the single copy line entails a swappable 
recombination site for exchange of transgene so that cell lines which are otherwise “identical” but with 
different transgenes can be systematically compared.  Through meta-analysis of archived transcriptome 
data we identified genes with different dynamics of expression patterns that can be useful for the dynamic 
control of cell behavior. CRISPR/Cas9 was employed to knock in a GFP between the first exon of the 
TXNIP gene and its endogenous promoter. Interestingly, the transcript levels of GFP in all investigated 
clones fell in a small range, but the dynamic profile was variable among them. In single copy clones of GFP 
reporter and IgG transgene, the transcript levels varied widely reflecting the probabilistic nature of their 
integration in the genome. The IgG titer and their transcript level of the clones also varied over a wide 
range. Overall, the result does not reveal a correlation between the transgene transcript level and the 
expression of the gene at the locus. Importantly, a number of clones showed a very high IgG transcript 
level, consistent with our previous report of a high transgene level prior to transgene amplification. The 
genomic context that may contribute to the variability, e.g. genomic consistency among the clones in terms 
of chromosome number, karyotype, and CGH, is being investigated.  
The implications of our findings to date and our work on implementing metabolic model prediction 
in this designing CHO cell line will be discussed. Although this work represents only an early step toward 
system engineering to cell line development, we believe such approaches will open new avenues to engineer 
cell lines and influence process development of biologics manufacturing in the coming years. 
